News

SPERA PHARMA made a debut exhibit at CPhI worldwide 2017, which was held for three days from October 24, 2017 in Frankfurt, Germany. Details of the SPERA PHARMA business model and technologies were actively pr...

A researcher in the Chemical R&D Division of SPERA PHARMA, Osamu Yabe, gave a poster presentation (2P-076) at The 35th Medicinal Chemistry Symposium, which was held on October 25∼27 in the Toyota Lecture Hall ...

SPERA PHARMA exhibited a company's booth at The 35th Medicinal Chemistry Symposium held at Nagoya University (October 25∼26). Many attendees from pharmaceutical companies, venture companies and academia visit...

Chirality 2017; 29th International Symposium on Chiral Discrimination (ISCD-29）was held at Waseda University International Conference Center on July 9-12. This international symposium emphasizes chirality as...

The 21st Workshop on Pharmaceutical Technology Succession was held by the Academy of Pharmaceutical Science and Technology, Japan (APSTJ) at Dome-mae campus of Meijo University on Friday, July 14, 2017, and Mr...

The article on API process research described by Misayo Sera and Hideya Mizufune in SPERA PHARMA was published in Tetrahedron. (Integrated Pd-catalyzed cross-coupling strategies for furnishing α-carbolines, T...

Researchers, Sayuri Hirano and Kazushi Hosoi of Chemical R&D Division gave the two poster presentations at 2017 Summer Symposium of The Japanese Society for Process Chemistry (JSPC) held on August 3 - 4 at Osa...

At Interphex 2017, held from June 28 at the Tokyo Big Sight, SPERA PHARMA, a newly launched member of the Bushu Pharmaceuticals Group, exhibited its services for the first time. Despite the short notice, more ...

Under a strategic partnership with Takeda Pharmaceutical Company, the Bushu Pharmaceuticals Group began conducting business on July 1, 2017, after a group of specialized CMC researchers and technicians at Take...